232 related articles for article (PubMed ID: 20196803)
21. Consumption of plant sterols reduces plasma and hepatic triglycerides and modulates the expression of lipid regulatory genes and de novo lipogenesis in C57BL/6J mice.
Rideout TC; Harding SV; Jones PJ
Mol Nutr Food Res; 2010 May; 54 Suppl 1():S7-13. PubMed ID: 20333723
[TBL] [Abstract][Full Text] [Related]
22. Liver gene expression in relation to hepatic steatosis and lipid secretion in two duck species.
Hérault F; Saez G; Robert E; Al Mohammad A; Davail S; Chartrin P; Baéza E; Diot C
Anim Genet; 2010 Feb; 41(1):12-20. PubMed ID: 19781035
[TBL] [Abstract][Full Text] [Related]
23. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
24. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
25. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
[TBL] [Abstract][Full Text] [Related]
26. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.
Mirandola S; Osterreicher CH; Marcolongo M; Datz C; Aigner E; Schlabrakowski A; Realdon S; Gerotto M; Alberti A; Stickel F
Liver Int; 2009 Apr; 29(4):557-65. PubMed ID: 19018985
[TBL] [Abstract][Full Text] [Related]
27. Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-alpha: independent and interactive roles in the regulation of lipid metabolism.
Sampath H; Ntambi JM
Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):84-8. PubMed ID: 16477170
[TBL] [Abstract][Full Text] [Related]
28. HCV liver infection and liver steatosis: evidence for indirect mechanisms in genotype 3?
Grassi A; Ballardini G; Susca M; Bianchini F; Bonoli S; Bianchi FB; Lenzi M
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():79-82. PubMed ID: 16225480
[TBL] [Abstract][Full Text] [Related]
29. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
Rodríguez-Torres M; Govindarajan S; Solá R; Clumeck N; Lissen E; Pessôa M; Buggisch P; Main J; Depamphilis J; Dieterich DT
J Hepatol; 2008 May; 48(5):756-64. PubMed ID: 18314217
[TBL] [Abstract][Full Text] [Related]
30. Mulberry extract inhibits oleic acid-induced lipid accumulation via reduction of lipogenesis and promotion of hepatic lipid clearance.
Ou TT; Hsu MJ; Chan KC; Huang CN; Ho HH; Wang CJ
J Sci Food Agric; 2011 Dec; 91(15):2740-8. PubMed ID: 22002411
[TBL] [Abstract][Full Text] [Related]
31. AMP-activated protein kinase and carbohydrate response element binding protein: a study of two potential regulatory factors in the hepatic lipogenic program of broiler chickens.
Proszkowiec-Weglarz M; Richards MP; Humphrey BD; Rosebrough RW; McMurtry JP
Comp Biochem Physiol B Biochem Mol Biol; 2009 Sep; 154(1):68-79. PubMed ID: 19427916
[TBL] [Abstract][Full Text] [Related]
32. Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication.
García-Mediavilla MV; Pisonero-Vaquero S; Lima-Cabello E; Benedicto I; Majano PL; Jorquera F; González-Gallego J; Sánchez-Campos S
Lab Invest; 2012 Aug; 92(8):1191-202. PubMed ID: 22641099
[TBL] [Abstract][Full Text] [Related]
33. Alcohol and lipid metabolism.
Crabb DW; Liangpunsakul S
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S56-60. PubMed ID: 16958674
[TBL] [Abstract][Full Text] [Related]
34. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
[TBL] [Abstract][Full Text] [Related]
35. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
Lemoine M; Barbu V; Girard PM; Kim M; Bastard JP; Wendum D; Paye F; Housset C; Capeau J; Serfaty L
AIDS; 2006 Feb; 20(3):387-95. PubMed ID: 16439872
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus-induced steatosis: an overview.
Negro F
Dig Dis; 2010; 28(1):294-9. PubMed ID: 20460926
[TBL] [Abstract][Full Text] [Related]
37. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.
Khan M; Jahan S; Khaliq S; Ijaz B; Ahmad W; Samreen B; Hassan S
Arch Virol; 2010 Nov; 155(11):1735-53. PubMed ID: 20842391
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
Le Hellard S; Mühleisen TW; Djurovic S; Fernø J; Ouriaghi Z; Mattheisen M; Vasilescu C; Raeder MB; Hansen T; Strohmaier J; Georgi A; Brockschmidt FF; Melle I; Nenadic I; Sauer H; Rietschel M; Nöthen MM; Werge T; Andreassen OA; Cichon S; Steen VM
Mol Psychiatry; 2010 May; 15(5):463-72. PubMed ID: 18936756
[TBL] [Abstract][Full Text] [Related]
39. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.
Wedemeyer I; Bechmann LP; Odenthal M; Jochum C; Marquitan G; Drebber U; Gerken G; Gieseler RK; Dienes HP; Canbay A
J Hepatol; 2009 Jan; 50(1):140-9. PubMed ID: 19019483
[TBL] [Abstract][Full Text] [Related]
40. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
